Back to calendar
Gossamer Bio, Inc. (GOSS) Earnings
GOSS reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.05
Actual EPS: $-0.08
EPS surprise: 35.19%
Company overview
Market Cap$83.2M
PriceUSD 0.17
EPS (TTM)-0.70
52-week high3.87
52-week low0.11
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees162